VTV THERAPEUTICS INC- CL A (VTVT) Fundamental Analysis & Valuation

NASDAQ:VTVT • US9183852048

Current stock price

31.97 USD
+2.57 (+8.74%)
Last:

This VTVT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. VTVT Profitability Analysis

1.1 Basic Checks

  • VTVT had negative earnings in the past year.
  • In the past year VTVT has reported a negative cash flow from operations.
  • VTVT had negative earnings in each of the past 5 years.
  • VTVT had a negative operating cash flow in each of the past 5 years.
VTVT Yearly Net Income VS EBIT VS OCF VS FCFVTVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -30.00%, VTVT is in the better half of the industry, outperforming 65.63% of the companies in the same industry.
  • With a decent Return On Equity value of -41.86%, VTVT is doing good in the industry, outperforming 66.60% of the companies in the same industry.
Industry RankSector Rank
ROA -30%
ROE -41.86%
ROIC N/A
ROA(3y)-87.35%
ROA(5y)-74.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VTVT Yearly ROA, ROE, ROICVTVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K -5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for VTVT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VTVT Yearly Profit, Operating, Gross MarginsVTVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. VTVT Health Analysis

2.1 Basic Checks

  • VTVT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for VTVT has been increased compared to 1 year ago.
  • The number of shares outstanding for VTVT has been reduced compared to 5 years ago.
  • VTVT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VTVT Yearly Shares OutstandingVTVT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
VTVT Yearly Total Debt VS Total AssetsVTVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • VTVT has an Altman-Z score of -2.45. This is a bad value and indicates that VTVT is not financially healthy and even has some risk of bankruptcy.
  • VTVT has a Altman-Z score (-2.45) which is comparable to the rest of the industry.
  • VTVT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.45
ROIC/WACCN/A
WACC9.44%
VTVT Yearly LT Debt VS Equity VS FCFVTVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

2.3 Liquidity

  • VTVT has a Current Ratio of 13.54. This indicates that VTVT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 13.54, VTVT belongs to the top of the industry, outperforming 88.74% of the companies in the same industry.
  • A Quick Ratio of 13.54 indicates that VTVT has no problem at all paying its short term obligations.
  • The Quick ratio of VTVT (13.54) is better than 88.74% of its industry peers.
Industry RankSector Rank
Current Ratio 13.54
Quick Ratio 13.54
VTVT Yearly Current Assets VS Current LiabilitesVTVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. VTVT Growth Analysis

3.1 Past

  • VTVT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.98%.
  • Looking at the last year, VTVT shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)1.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.45%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • VTVT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.12% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-6.38%
EPS Next 2Y-14.53%
EPS Next 3Y-8.74%
EPS Next 5Y9.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VTVT Yearly Revenue VS EstimatesVTVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
VTVT Yearly EPS VS EstimatesVTVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -50 -100

More info and screens

Find the best growth stocksShow best growing peers

0

4. VTVT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VTVT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VTVT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VTVT Price Earnings VS Forward Price EarningsVTVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VTVT Per share dataVTVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • A cheap valuation may be justified as VTVT's earnings are expected to decrease with -8.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.53%
EPS Next 3Y-8.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VTVT Dividend Analysis

5.1 Amount

  • No dividends for VTVT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VTVT Fundamentals: All Metrics, Ratios and Statistics

VTV THERAPEUTICS INC- CL A

NASDAQ:VTVT (4/28/2026, 8:05:06 PM)

31.97

+2.57 (+8.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-10
Earnings (Next)05-13
Inst Owners32.55%
Inst Owner Change0%
Ins Owners0.42%
Ins Owner Change0%
Market Cap125.96M
Revenue(TTM)N/A
Net Income(TTM)-26.97M
Analysts83.64
Price Target56.3 (76.1%)
Short Float %3.75%
Short Ratio1.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.85%
Min EPS beat(2)-8.04%
Max EPS beat(2)47.74%
EPS beat(4)2
Avg EPS beat(4)9.43%
Min EPS beat(4)-9.33%
Max EPS beat(4)47.74%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.81%
PT rev (3m)16.83%
EPS NQ rev (1m)-0.6%
EPS NQ rev (3m)25.44%
EPS NY rev (1m)12.3%
EPS NY rev (3m)21.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.95
P/tB 1.95
EV/EBITDA N/A
EPS(TTM)-3.35
EYN/A
EPS(NY)-3.56
Fwd EYN/A
FCF(TTM)-6.41
FCFYN/A
OCF(TTM)-6.41
OCFYN/A
SpS0
BVpS16.35
TBVpS16.35
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -30%
ROE -41.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-87.35%
ROA(5y)-74.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.54
Quick Ratio 13.54
Altman-Z -2.45
F-Score4
WACC9.44%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.45%
EPS Next Y-6.38%
EPS Next 2Y-14.53%
EPS Next 3Y-8.74%
EPS Next 5Y9.12%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.21%
OCF growth 3YN/A
OCF growth 5YN/A

VTV THERAPEUTICS INC- CL A / VTVT Fundamental Analysis FAQ

What is the fundamental rating for VTVT stock?

ChartMill assigns a fundamental rating of 3 / 10 to VTVT.


What is the valuation status for VTVT stock?

ChartMill assigns a valuation rating of 0 / 10 to VTV THERAPEUTICS INC- CL A (VTVT). This can be considered as Overvalued.


What is the profitability of VTVT stock?

VTV THERAPEUTICS INC- CL A (VTVT) has a profitability rating of 1 / 10.


Can you provide the financial health for VTVT stock?

The financial health rating of VTV THERAPEUTICS INC- CL A (VTVT) is 7 / 10.